{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:07:17Z","timestamp":1791295637471,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1097\/md.0b013e3181568ec0","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T17:20:51Z","timestamp":1236187251000},"page":"269-277","source":"Crossref","is-referenced-by-count":60,"title":["Substitution of Methotrexate for Cyclophosphamide in Wegener Granulomatosis"],"prefix":"10.1097","volume":"86","author":[{"given":"Alexandra","family":"Villa-Forte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Mascha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Karafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Roberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Langford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210309","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1172\/JCI116884","article-title":"The anti-inflammatory mechanism of methotrexate.","volume":"92","author":"Cronstein","year":"1993","journal-title":"J Clin Invest"},{"key":"R2-2-20210309","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Jayne DRW (European Vasculitis Study Group). Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R3-2-20210309","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/art.1780391215","article-title":"Therapy for maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis.","volume":"39","author":"De Groot","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R4-2-20210309","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/art.1780170404","article-title":"Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis.","volume":"17","author":"Fauci","year":"1974","journal-title":"Arthritis Rheum"},{"key":"R5-2-20210309","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"R6-2-20210309","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients.","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"R7-2-20210309","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.1780351113","article-title":"The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate.","volume":"35","author":"Hoffman","year":"1992","journal-title":"Arthritis Rheum"},{"key":"R8-2-20210309","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"R9-2-20210309","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E","article-title":"A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance.","volume":"42","author":"Langford","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R10-2-20210309","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/1529-0131(200008)43:8<1836::AID-ANR20>3.0.CO;2-R","article-title":"Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerulonephritis.","volume":"43","author":"Langford","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R11-2-20210309","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R12-2-20210309","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.1780380505","article-title":"An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.","volume":"38","author":"Sneller","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R13-2-20210309","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","article-title":"Luqmani RA; International Network for the Study of the Systemic Vasculitides (INSSYS). A disease specific activity index for Wegener's granulomatosis.","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R14-2-20210309","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis.","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"key":"R15-2-20210309","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1172\/JCI112922","article-title":"Selective effects of cyclophosphamide therapy on activation, proliferation and differentiation of B cells.","volume":"79","author":"Zhu","year":"1987","journal-title":"J Clin Invest"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e3181568ec0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:45:53Z","timestamp":1786038353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-200709000-00002"}},"subtitle":["A 12-Year Single-Practice Experience"],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181568ec0","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}